Abstract
Introduction
Although the ratio of the number of journal articles published to scientist and the number of scientists per journal has remained essentially constant since the 1700s (Bennion, 1994) , the large increase in the number of scientists has led to a large increase in the number of journals and articles in each journal; between 1665 and the present, approximately 40 000 journals have been created (Goodstein, 1993) . The number of scientific journals currently being published is vastly greater than any single person can read, and in fact it is not expected that such should be attempted. Rather, scientists read only those journals reporting work within their specialty. Thus, the continuing increase in the number of journals has resulted in a continuing narrowing of specialization. This is not a completely satisfactory response, however, because information relevant to even a narrow specialty is dispersed among thousands of sources, and because increased specialization reduces the opportunity for crossfertilization of ideas.
An alternative response to the increase in publications is to increase the efficiency of information retrieval. This would require that biomedical research information be retrievable with close to 100% of recall (proportion of relevant articles retrieved from the database) and precision (proportion of relevant articles in the retrieved set). Such an improvement in biomedical information retrieval technology would allow for a system analogous to the just-in-time inventory system of modern manufacturing, a capability referred to as information on demand. This would free researchers from the burden of browsing the scientific literature solely for the purpose of noting information that might someday be required, would allow them to directly access information only as required, and thus would give researchers practical access to a significantly wider (less specialized) range of scientific information than is now the case. The field of information retrieval provides one approach to improving access to biomedical data. Classically, information retrieval deals with improving recall and precision of access to text databases (Hersh, 1996) . PubMed, which allows one to search for relevant publications using either a controlled vocabulary index (MESH) or an index of words in the titles, abstracts, or other parts of a publication document, is perhaps the most well known system of this kind. The development of systems for accessing highly structured databases is not normally considered part of information retrieval (Hersh, 1996) . If a significant fraction of the information in the scientific literature could be placed into such databases, however, searches of high precision and recall would be enormously simplified. Some of the problems that would need to be overcome to make this possible are defining data structures that can encode the full richness of biomedical research information, developing techniques for efficient encoding of this information, and developing tools for simple yet efficient retrieval of this information.
Databases of biomedical information can be grouped in a variety of different ways. Traditionally, such databases have been divided into bibliographic databases such as MEDLINE and factual databases such as Genbank (Benson et al., 1999) or Online Mendelian Inheritance in Man OMIM (1999) . MEDLINE and other bibliographic databases return lists of citations which are related to the search topic. The facts that are required are then found in the cited publications. Factual databases return the requested data directly. More recently, this distinction has blurred. The abstracts present in many modern bibliographic databases contain significant factual information.
[Although selected MEDLINE records retrieved from Entrez/PubMed are now linked to the full text of cited articles (Butler, 1999) , only the abstract can be searched.] Conversely, Genbank and OMIM records contain the underlying citations for the facts that they provide. Hersh (1996) divides databases into Text Databases and Structured Databases. Structured Databases typically store their data in a number of related tables with each table containing many fields. Data stored in the fields of these tables is, in general, simple, atomic and has defined values. Text databases tend to be simpler, with fewer tables and fewer fields per table. Such databases store much of their information in a large text field, and the information in this field is complex, non-atomic, and expressed as natural language. Text databases are the traditional targets for the field of information retrieval (Hersh, 1996) .
A third division, reviewed by Schatz (1997) , focuses on degrees of searchability. This approach to classifying scientific information sources sees a progression from text searching to document searching to concept searching. Text searching describes a search like that done in PubMed where only a portion of the information in the document is available for searching. In document searching, all the information in the document can be searched. Searches of OMIM and Genbank represent document searching. Although an improvement over Text Searching, Document Searching suffers from the problem that, if the author uses different words to describe the concept you are interested in than you use to search for it, your search will fail. The defining feature of Concept Searching is that matches are by concept rather than words, alleviating this problem. One common way that the field of information retrieval facilitates concept searching is through the use of thesauri which map the various words and phrases that mean the same thing onto a common search term. Because the meaning of a term can be context dependent, such thesauri can become quite complex if they must work against a text database.
We believe that highly structured databases covering a broad range of scientific information ought to be explored as an alternative to text databases. To develop a fully structured database covering the entire domain of biomedical research represents an overwhelming task. To reduce this task to a manageable one, we both restricted the domains of information contained within our databases and partially structured our databases. These intermediate stages provide feedback to direct future efforts, are useful in their own right, and over time, both the degree of structuring and range and breadth of the domains covered can be increased. In the present study, we developed two test bed databases, the Tumor Gene Database (TGDB) and the Mammary Transgene Database (MTDB) and exposed these databases to both curators and users. Curators were able to efficiently enter data into the databases and a significant number of users found the databases of value, providing the prerequisites of a test bed for further system development. Our experience in developing these databases and the descriptive information we obtained on their use both suggested directions for continued development and confirmed that a formal study of their utility will be feasible.
Systems and methods
The production version of Digital Reviews in Molecular Biology (DRMB) is implemented in the 4th dimension (ACI) relational database package running under Mac OS. The relational database model was chosen for storage of DRMB because it is mature, secure, and portable; for example, an experimental version of DRMB has been ported into an SQL RDBMS (MySQL) under the Linux operating system accessed via CGI code written in the Python programming language. The production version of DRMB runs on a PowerComputing PowerTower 604e computer running at 180 MHz. The Netlink 4D database extension (Foresight Technology) was used to facilitate linkage between the database and the World Wide Web (WWW). The WWW front end, business rules, and other features of the database are implemented in over 5000 lines of code written in the 4th Dimension scripting language.
Usage of the database was estimated by post-processing of simple log files generated by the DRMB software. These log files were generated from data supplied by the WebSTAR http server software to the Netlink 4D software which was first saved to a table within the database by code in the 4D scripting language. Periodically, the contents of that table were exported to the Macintosh file system and a script written in Perl was used to generate a cumulative digest containing the date and time of the access, the domain name of the accessing user, the particular function within DRMB which was accessed, the URL of the site from which the user came, and the identification string of the browser. HTTP GET arguments were part of the function returned, but POST arguments were not. In our analysis, we equated IP addresses with users, a good if not perfect approximation.
Algorithm and implementation

Data structure
Figures 1 and 2 illustrate entity/relationship diagrams of the data models for TGDB and MTDB, respectively and Figure 3 the schema of the physical database containing them. The fundamental data structure of TGDB is exceedingly simple. The central entity in TGDB is the gene, which has a number of attributes, 31 in the current version of the database (listed in the legend for Figure 1 ). These attributes represent basic facts about a tumor gene that a biomedical research scientist, working in molecular carcinogenesis, will want to know about a gene; the molecular mass of its protein, the size of its RNA, what kind of tumors it is associated with, how it is regulated, what its biochemical function is, etc.
A number of factors complicate implementation of the simple data structure of TGDB resulting in the somewhat complex relational schema shown in Figure 3 . The most significant complicating factor is that each fact is referenced to its (literature) source, and that the same, similar, or related facts may be reported by a number of laboratories. Primarily for this reason and secondarily to facilitate the convenient addition of attributes, the attributes of a gene are not part of the Gene entity, but rather constitute a new entity, the Fact. Facts have relationships to Genes and to the References from which they were obtained.
Each Gene entity has a Name attribute, but an unfortunate reality of this domain is that the same gene is frequently known by several names. We used a simple thesaurus, implemented as a Name entity, which allows Elmasri and Navathe (1989) was used except that we added the concept of Internet linkage to resources outside the DBMS. Such linkages are shown using the ∼> symbol, with the arrow pointing from the Entity in the database to the Internet resource. searches to retrieve a gene using any of the names by which it is known. Although some genes are associated with a MESH term, this is not a satisfactory solution to the multiple name problem for two reasons. First, only 13 of the 58 genes in BCGD were associated with a MESH term. Second, many papers about these 13 genes lack the MESH term. For example, of the 5175 BCL2 papers we identified in PubMed, only 648 of them have the BCL2 MESH term associated with them.
TGDB is subdivided into a set of logical databases. At present, these consist of TGDB (the whole database), BCGD (those genes and facts relevant to Breast Cancer) and OrCDB (those genes and facts relevant to Oral Cancers), with further subdivisions anticipated. The purpose of these subdivisions is to conveniently provide to workers within these domains those facts relevant to their work. These subdivisions require a set of relational tables to implement. Finally, additional tables were required to implement this Entity/Relationship (Elmasri and Navathe, 1989) design within the relational model and/or to provide utility functions.
Despite the increased complexity that developed around TGDB, its fundamentally simple design results in an extremely flexible database; by addition of appropriate attributes, virtually any fact about a gene can be included. As a result, this form of the database has been effectively used by a number of curators to store information about tumor genes. We would expect that this structure would be useful for other gene databases (transcription factor databases, receptor databases) but have not tested this hypothesis. However, the range of biological information that can be stored in such a simple structure would be expected to be limited. Thus, we developed a different data model for storing the information of the MTDB. One important concept in the design of the MTDB data structure was that of the transgene construct. As modeled in MTDB, a transgene construct derives from two genes; one of which provides regulatory sequences and one that provides coding sequences. A second factor which influenced the data model of MTDB was the requirement that there be a degree of structuring on one subset of its data; that describing the level of expression. There are many incompatible ways of expressing the level of expression; quantitative or qualitative, and within quantitative measures, values are expressed in a variety of different units. The relationship between the different units may not be readily available to the curator or even known at all, making it infeasible to convert data to a common set of units. To model the level of expression, we split the measure of level of expression into two parts; a free-form, TGDB-like part, equivalent to the Fact field of the Facts table of TGDB which describes expression in the way it was expressed in the original literature reference, and a subjective grouping of level of expression into High, Medium, and Low, to facilitate searching of the database by users. Species is an important concept in this domain, and thus Species was structured as a controlled vocabulary (species names) coupled with some descriptive information. Finally, the primary curator of MTDB (S.Y.) felt that facts could be best understood if grouped in a particular way. This group of facts was implemented as the Experiment.
Although we developed a new data model for MTDB, many features common to TGDB and MTDB were shared in DRMB. The concept of a Curator, required for data entry, is common, as is the list of references. For both TGDB and MTDB, each curator has his or her own list of literature references, stored in the Ed2Ref table. Although MTDB defines the unique Construct entity, the regulatory and structural components of that construct are linked to the same Gene table as that used by TGDB. (This is facilitated by the Database entity described above.) Finally, although literature references refer in most cases back to MEDLINE and can be retrieved from Entrez, both to support references not in MEDLINE and to improve performance, a local copy of all references for both databases is cited in the References.
In addition to DRMB links to MEDLINE (Entrez, 1999) , TGDB also has links to four other external databases on the WWW; Genbank (1999) , OMIM (1999), GeneCards (Rebhan et al., 1998) and GDB (Letovsky et al., 1998) . (The links to Genbank, and GDB are not yet available to users.)
User interface
The search tools we generated for the users were designed for simplicity of both development and use rather than to accommodate every possible search. For TGDB, we implemented two kinds of searches. The first searches the list of Names for a link to a Gene. By use of wildcards a user can search for all the ras genes by searching for @ras@, or even return a list of all the genes in the To maximize the number of users that could conveniently access the databases, our search interface is WWW-based and made available over the Internet. Biomedical research databases with WWW-based retrieval systems are now common because of the advantages of remote access, platform independence and minimal barrier to initial use. Less common are WWWbased data entry front ends. Because we hope to recruit a range of curators from institutions around the world, we chose to implement a WWW-based interface for curators. We have successfully tested data entry from as far away from Houston, Texas (where the database resides) as Lebanon and Saudi Arabia.
Evaluation
To determine if our implementation was sufficiently functional to justify continued development and rigorous testing, and to provide direction for further development, we tested both the data entry and the data retrieval capabilities of the database.
Data entry
For maintaining the database, the current WWW-based interface allows MTDB curators to enter Experiments, Constructs, and Genes into the database, and TGBD curators to enter Facts and Genes. Previously entered facts can also be edited through this interface.
TGDB was seeded with 2278 facts from 1148 papers entered into its parent databases by one of us (D.L.S.) between 1982 and 1997. Subsequently, nine curators have tested the interface, and significant data entry was accomplished by one (R.A.B.), who, working full time on the project for 10 months (February 20, 1997 to December 20, 1997) entered 1922 facts. 1547 of these facts were approved for publication by the Breast Cancer Gene Database editorial board (Baasiri et al., 1999) . This collection of information constitutes a significant fraction of the relevant data related to Breast Cancer.
Test entry was done by two of us (D.A.W., A.E.L.), by two volunteer students at Baylor College of Medicine, a volunteer faculty member at Baylor College of Medicine, by R.A.B., and by five candidates for the position of database curator as part of their job interview. The latter group had no previous training and was asked to enter as much information as possible within 1 h. An average of 30 facts from 10.4 papers (11-51 facts, from 3-20 papers) was entered. This represents the mechanical limitations of the system; the time required for filling out a form and for the software to process the data and return a new form. By comparing that rate to the rate achieved by R.A.B., it is apparent that actual data entry takes much more time; time required to select and read papers, to discuss the facts with the editorial board, to revise facts prior to publication, etc. Thus, neither the DRMI software nor network access delays are bottlenecks for data entry.
The error rate of curators is quite low. In the case of BCGD (curated by R.A.B.), each of the facts was examined by an editorial board prior to publication, and any errors found were removed. In the case of the job candidates, examination of the facts resulted in the identification of no factual errors. Nonetheless, these entries, as well as the entries of one of the volunteer students, were of low quality and were not considered for publication. Although factual errors are quite rare, placing an entry under the wrong topic or failure to summarize a fact clearly and consistently are the most common problems. We have learned that training is required for effective data entry. Training consists of accessing the database as a user and reading a selection of facts (typically a few hundred) to develop a sense of how facts are summarized, study of our topic definitions, and two to three cycles of entering approximately 20 facts and discussing them with an experienced user. Thereafter, review by an editorial board will both remove poor quality entries and continue the training process.
Measuring the completeness of the database is difficult due to the absence of a 'gold standard' with which to compare. Table 1 contains a variety of metrics we have used to estimate completeness. One obvious measure is to ask, for each gene, what percentage of the topics have one or more facts associated with them. For the 58 genes of the BCDG, genes have data for between 1/47 and 32/47 topics, with an average of 10/47 topics (Table 1) . However, in the absence of a gold standard, it is not possible to determine which of these result from the absence of that information in the scientific literature and which information we have not yet encoded. Another measure is to ask what fraction of the publications identified for each gene have been used as the basis of one or more facts. Because R.A.B. did most of her work in 1997 and focused on papers published in 1996, limiting the examination to that year provides a measure of the feasibility of maintaining the database up to date and what resources would be required. Considering 1996 publications on the 58 BC genes, the percentage of identified PubMed references used varied between <1% and 100%, with an average of 26%.
Of course, a resource need not reference all of PubMed This search returns about 800 papers a month, much more than any one curator can examine. For her work on BCGD, R.A.B. altered this search in two complementary ways. First, she restricted the search using the AND operator to join it with: "breast neoplasms"[MeSH Terms] This retrieves about 50 papers a month and is a more restrictive term than is desired. To retrieve papers not retrieved using the above search but relevant to BCGD, R.A.B. supplemented it with searches for all the data about selected genes. This typically resulted in retrieving citations for more papers than she could obtain, much less read and thus, for most papers, only the abstract supplied by MEDLINE was used for data entry. In these cases, the value added over and above what is provided by MEDLINE itself is the indexing and reorganization of the data in MEDLINE, and in some cases expert translation, e.g. to convert a variant gene name into a canonical one. This, in fact, represents a very significant increase in value. For a few papers, either identified while entering abstract data or identified by the conventional approaches outlined above, data from the full paper was entered. Such data is not searchable in MEDLINE. Of the published facts in BCGD entered by R.A.B., 1299 came from abstracts, 251 from full papers, and 100 from reviews.
Data entry into MTDB was done by one of us (S.Y.) working as a volunteer while a postdoctoral fellow. Over a period of approximately 18 months, 102 experiments and 86 constructs were entered into the database. Although data entry was largely accomplished using the local client tools of the DBMS system before the WWW interface was completed, the last 12 experiments and 11 constructs were entered via the WWW interface to verify its functionality. Unlike the case of TGDB, the domain covered by MTDB is poorly indexed by MEDLINE, probably because it is agricultural rather than medical in nature. Thus, papers for MTDB were selected entirely using conventional approaches and full papers were used for all data entry.
Data retrieval TGDB has been available on the Internet in a variety of forms since 1990, thus providing a pool of users. The BCGD front end to TGDB was announced on Bionet and at the 20th Annual San Antonio Breast Cancer Symposium held in San Antonio, Texas in November, 1997. MTDB was announced at the meeting 'Exploiting Transgenic Technology for Commercial Development' in San Diego, California in November, 1995. Currently, TGDB averages about 50 accesses a day and MTDB about 13, sufficient for a preliminary evaluation of its functionality.
A rigorous evaluation of a database resource is a significant effort and we are currently seeking funding for such an evaluation of DRMB. Although the simple log files currently available are insufficient for such a detailed analysis, these files can serve as a preliminary indicator of how useful the DRMB databases are to users. To that end, we asked three questions.
1. How often did user searches retrieve information from the database?
2. How deep into the database were users encouraged to go?
3. What fraction of users were encouraged to return to the database?
Although these questions do not unambiguously measure database value, affirmative answers do suggest value, and more to the point, indicate that there is sufficient interest in the user community to drive a rigorous evaluation. As is described above, there are three different ways of searching DRMB; a search for gene names in TGDB, a search for words used in the facts in TGDB, and a search for experiments in MTDB which use certain gene sequences and/or which evidence certain levels of RNA and/or protein expression or activity or secretion. Whether a search successfully retrieved data from the database could not be determined directly from the log files. Rather, post-processing of the log files was used to estimate what fraction of searches would be successful. For a variety of reasons, we have taken different approaches to analysing these three searches.
Analysis of gene name searches of TGDB was the simplest, as the name searched is available in the log files, and because each search is for a single name. For each name searched, we asked if that name was currently present in the database. During our evaluation period of October 9, 1996 through October 9, 1998, there were 10 009 gene name searches of TGDB. Of these, 6550 were searches for names that have been searched for at least three times, and that therefore appear to represent serious searches. These 6550 searches represent 460 different names. Of the names requested in these serious searches 86% were found in the database (as compared with 65% of all the names searched for), and, because the more common names were more likely to be in the database, over 90% of the searches resulted in retrieval of information. Most of the remaining approximately 3000 searches apparently represent typing errors, misspellings, or frivolous searches by casual visitors. Finally, almost all visits (7082 of 7091) which contained a gene name search resulted in at least one successful gene name search; an unsuccessful search was frequently followed by a successful one, where a spelling error might be corrected, for example.
We examined in detail the 169 names which were searched for three or more times but which were not present in the database. Of these, 60 represented genes not present in the database and another 27 represented names not present in our synonym list but which represented genes which were in the database. Four of these names could have been recognized by an improvement in our subroutine that looks for name variants. Of the names searched for, 82, roughly half of the total, could be classified as user errors; 46 looked like key words that should have been searched using the key word search, 28 represented incorrect name variants (most commonly extraneous words or punctuation that would be difficult to reliably convert to a canonical form) and eight represented spelling errors.
Because searches of TGDB for words in facts allows the entry of multiple words which are combined using the OR logical operator, there are too many unique word searches to evaluate, and evaluating the presence of each word in the database is not a meaningful estimator. Thus, we queried the database for the last 1000 word searches. Although 57% were successful overall, a qualitative examination of the searches revealed a significant confounding factor; many of the searches almost certainly represent user errors. Some of the words contained punctuation apparently resulting from attempts by users to coerce the system into searches of which it is not capable. Such punctuation or words which otherwise appeared not to be grammatically valid were contained in 3.5% of searches. Similarly, many searches which used reasonable words nonetheless appeared to be attempts to identify phrases or a sets of words joined by the AND logical operator. For example, a search might be for 'genetically linked disease'. What is retrieved from DRMB are all of the facts that contained any of the three words individually, which is unlikely to be what was desired. Over 22% of searches represented such word phrases. When both of these kinds of errors were removed, 51% of the remaining searches retrieved one or more facts. Included among these were many that were searches for gene names. Although these might be mistaken attempts to search for a gene by name, an alternative explanation is that these represent searches for facts about one gene which mention a different gene in the fact or comment (e.g. a fact about HRAS which mentions that it genetically complements MYC). Thus, such searches were not eliminated. Based on this qualitative assessment of what users appeared to be attempting, we have recently designed and implemented an additional search page for TGDB which unifies the name and fact searches (e.g. allows a user to search for a gene name which either appears as a name or which occurs in the fact) and which substitutes phrase searching for the logical OR of the entered words used in the first generation fact search.
To evaluate searches of MTDB, we took advantage of the fact that the results returned from such a search are not very informative; a user needs to 'click-through' to obtain detailed information on experiments or constructs. Because unsuccessful searches would not result in a clickthrough, we used click-through frequency as an estimator of success. Analysis of the log files indicate that over 35% of MTDB searches were followed by such a clickthrough. It should be noted that this click-through rate is an underestimate of search success; unsuccessful searches cannot result in a click through, but successful searches need not result in a click through. By comparison, under 13% of word searches of TGDB were followed by a click-through (needed to obtain a complete gene record) compared to an over 50% retrieval rate measured by post-querying the database. However, some or all of this difference is likely due to the fact that much more data is returned from a TGDB word search, making clickthrough less necessary than for MTDB searches. Finally, because MTDB is currently more structured than TGDB, a negative result from an MTDB search is itself meaningful and thus should not necessarily be viewed as a failure. For example, should a user search for experiments using the alpha casein promotor to drive HRAS gene expression and find none, the fact that such experiments have yet to be performed might itself be the information required.
Thus, the answer to our first question is that most searches of DRMB result in data retrieval. The clickthrough rate also provides information as to the second question; to what depth are users encouraged to go into the database; in many cases, they are willing to drill down to find more information about what was retrieved from the database. Another datum relevant to that question is the length of a database visit. Initial interaction with the database occurs via 'front pages' for TGDB, BCGD, and MTDB, which are located on Baylor College of Medicine, Academic Informatics Services main server and these initial interactions are not counted. Thereafter, access switches to the Macintosh server where we begin logging usage. Thus, only users who persist past the home page are counted. Of these users, over 50% then access five or more pages.
Finally, by analysing which domain names visit the database and which of those visit the database more than once, an estimate of the utility of the databases can be obtained. Repeated visits to the databases were taken as an estimate of their perceived long-term value. Some of those who visit only once may have found all they needed on the first visit, and some of them represent casual web surfers who are not targets for this resource, but the fact that over 13% of users (980 out of 7096) return for one or more additional visits provides a lower limit estimate of the perceived long-term value of the database.
Discussion
Our long-term goal is to explore the utility of structured databases as an alternative to the text databases which are the traditional substrates for information retrieval technology. The short-term goal of the present work was to develop two first generation, DBMS-based systems which can contain virtually the full range of biological data (even if much of this is unstructured) within the domains they cover (tumor genes and transgene expression) that can be efficiently populated by curators and which are of sufficient interest to the scientific community to provide the user base needed to test their utility. Our success at having done this provides us with a platform we can use to develop more structured and more comprehensive databases.
One obvious disadvantage of structured databases relative to text databases is the work required to encode the text-based scientific literature into that structure. In the long run, we believe that this structuring ought to be the responsibility of authors who will be most qualified to correctly structure their data and will be motivated to do so if they believe that this will result in wider exposure of their work. Until the utility of structured databases has been fully documented, however, we expect that curators will recode data from the literature. One of the most gratifying results of this study was our finding that a significant database can be populated and maintained with relatively modest resources. Two useful databases were constructed largely from the efforts of one full time paid and one part time volunteer curator, and the resulting databases are of significant and continuing interest to the scientific community. Our full time curator was able to encode PubMed references at a rate sufficient to keep up with the rate of publication for 5.8 average genes, and at a rate that could maintain a depth of coverage equivalent to OMIM for 43.7 genes. A student who is also entering data into TGDB as a part time volunteer is encoding references at a rate sufficient to match the depth of coverage of OMIM for 5.4 genes. Thus, we believe that curator encoding of data from the literature is a viable transition strategy.
Given the success of this initial system, we can use our experience with these systems to design future generations. The goals of these future generations will be to incrementally increase the breadth of domains that they can cover and the degree of structuring of the data in the databases. Fully merging TGDB and MTDB ought to result in a system significantly more general than either. Some initial observations about how this might be done are as follows.
1. The concept of Fact has been a useful one. Although MTDB does not have an explicit Fact table, the attributes of Experiment (e.g. level of RNA expression, level of Secretion, Developmental Effects) function as Facts. However, to be useful in MTDB specifically and in a broader range of domains generally, the data structure for a Fact needs to be made more flexible. This might be accomplished using an object oriented approach, wherein a parental generic fact could be subclassed into facts customized for different data structures. Facts in MTDB would relate to transgene Constructs rather than to genes, for example.
2. Making the fact more flexible will also increase the possibility for data structuring. For TGDB, some facts like Chromosomal Location could be made quantitative (to allow searching for genes near each other, for example) and for others (Biochemical Type, Cell Location), replacement of the current free text field with a choice from a list would increase structure and significantly improve searchability.
3. The concept of the Experiment in MTDB suggests to us that the concept of Gene in TGDB is overloaded in a way limiting flexibility. One use of Gene in TGDB is as a subject for Facts. The other use is to organize groups of facts into something equivalent to the MTDB experiment; all facts about a gene. By separating these, we increase the flexibility of the Fact data type and generalize the Experiment data type (which would then be renamed).
In conclusion we found that it is possible to begin to structure the enormous and diverse amount of data in two areas of biomedical research, and that resulting databases are of sufficient interest to the user community to provide the driving force for a rigorous test of their utility and for future development.
